These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16477079)

  • 1. Src homology 2 domain-based high throughput assays for profiling downstream molecules in receptor tyrosine kinase pathways.
    Yaoi T; Chamnongpol S; Jiang X; Li X
    Mol Cell Proteomics; 2006 May; 5(5):959-68. PubMed ID: 16477079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
    Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
    J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
    O'Bryan JP; Lambert QT; Der CJ
    J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
    Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide inhibitors of src SH3-SH2-phosphoprotein interactions.
    Gilmer T; Rodriguez M; Jordan S; Crosby R; Alligood K; Green M; Kimery M; Wagner C; Kinder D; Charifson P
    J Biol Chem; 1994 Dec; 269(50):31711-9. PubMed ID: 7527393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling the global tyrosine phosphorylation state.
    Machida K; Mayer BJ; Nollau P
    Mol Cell Proteomics; 2003 Apr; 2(4):215-33. PubMed ID: 12754303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
    O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative multiplexed profiling of cellular signaling networks using phosphotyrosine-specific DNA-tagged SH2 domains.
    Dierck K; Machida K; Voigt A; Thimm J; Horstmann M; Fiedler W; Mayer BJ; Nollau P
    Nat Methods; 2006 Sep; 3(9):737-44. PubMed ID: 16929320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
    Case RD; Piccione E; Wolf G; Benett AM; Lechleider RJ; Neel BG; Shoelson SE
    J Biol Chem; 1994 Apr; 269(14):10467-74. PubMed ID: 8144631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of pp60c-src with two major signaling pathways in human breast cancer.
    Luttrell DK; Lee A; Lansing TJ; Crosby RM; Jung KD; Willard D; Luther M; Rodriguez M; Berman J; Gilmer TM
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):83-7. PubMed ID: 7506422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.
    Marengere LE; Pawson T
    J Biol Chem; 1992 Nov; 267(32):22779-86. PubMed ID: 1385407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SH2-PLA: a sensitive in-solution approach for quantification of modular domain binding by proximity ligation and real-time PCR.
    Thompson CM; Bloom LR; Ogiue-Ikeda M; Machida K
    BMC Biotechnol; 2015 Jun; 15():60. PubMed ID: 26112401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
    Lombardo CR; Consler TG; Kassel DB
    Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.
    Isakov N; Wange RL; Burgess WH; Watts JD; Aebersold R; Samelson LE
    J Exp Med; 1995 Jan; 181(1):375-80. PubMed ID: 7528772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing SH2 Domain Specificity and Network Interactions Using SPOT Peptide Arrays.
    Liu BA
    Methods Mol Biol; 2017; 1555():357-373. PubMed ID: 28092043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grb10 interacts differentially with the insulin receptor, insulin-like growth factor I receptor, and epidermal growth factor receptor via the Grb10 Src homology 2 (SH2) domain and a second novel domain located between the pleckstrin homology and SH2 domains.
    He W; Rose DW; Olefsky JM; Gustafson TA
    J Biol Chem; 1998 Mar; 273(12):6860-7. PubMed ID: 9506989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
    Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
    Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
    Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
    Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the SH2 binding specificity and kinase activity of Src by tyrosine phosphorylation within its SH2 domain.
    Stover DR; Furet P; Lydon NB
    J Biol Chem; 1996 May; 271(21):12481-7. PubMed ID: 8647855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.